Ken Research Logo

Global healthcare third party logistics market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

The Global Healthcare Third Party Logistics Market, valued at USD 260 Bn, is driven by demand for efficient supply chains, e-commerce, and temperature-sensitive product handling.

Region:Global

Author(s):Dev

Product Code:KRAA9579

Pages:92

Published On:November 2025

About the Report

Base Year 2024

Global Healthcare Third Party Logistics Market Overview

  • The Global Healthcare Third Party Logistics Market is valued at USD 260 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for efficient supply chain solutions, the rise in e-commerce for healthcare products, and the need for specialized logistics services to handle sensitive medical products, including pharmaceuticals and medical devices. Additional growth drivers include the expansion of biologics and specialty drugs, the adoption of advanced technologies such as real-time analytics and IoT tracking, and the growing trend of outsourcing logistics by pharmaceutical manufacturers and distributors to optimize costs and compliance requirements .
  • Key players in this market are concentrated in regions such as North America and Europe, where advanced healthcare infrastructure, stringent regulatory frameworks, and a high prevalence of chronic diseases drive demand for third-party logistics services. Countries like the United States and Germany are particularly dominant due to their robust healthcare systems and significant investments in logistics technology. The Asia-Pacific region is experiencing rapid growth, driven by expanding healthcare access and increasing pharmaceutical manufacturing capacity .
  • In 2023, the U.S. government implemented the Drug Supply Chain Security Act (DSCSA), which mandates enhanced security measures for the pharmaceutical supply chain. This regulation, issued by the U.S. Food and Drug Administration, requires all stakeholders, including third-party logistics providers, to adopt serialization and track-and-trace capabilities, ensuring the integrity and safety of drug distribution. The DSCSA establishes requirements for product tracing, verification, and licensing for wholesale distributors and third-party logistics providers, with phased implementation timelines and compliance obligations .
Global Healthcare Third Party Logistics Market Size

Global Healthcare Third Party Logistics Market Segmentation

By Type:The market is segmented into Cold Chain Logistics, Non-Cold Chain Logistics, Specialized Logistics Services, and Reverse Logistics & Returns Management. Cold Chain Logistics is crucial for transporting temperature-sensitive products such as vaccines, biologics, and specialty drugs, requiring precise temperature control and monitoring. Non-Cold Chain Logistics handles standard pharmaceuticals and medical devices that do not require refrigeration. Specialized Logistics Services cater to unique needs like clinical trials, investigational product management, and hazardous material handling. Reverse Logistics & Returns Management focuses on the collection, return, and safe disposal or redistribution of unused or expired healthcare products .

Global Healthcare Third Party Logistics Market segmentation by Type.

By End-User:The market is segmented into Pharmaceutical Companies, Medical Device Manufacturers, Hospitals and Healthcare Providers, Clinical Research Organizations (CROs), and Wholesalers & Distributors. Pharmaceutical Companies are the largest end-users due to the high demand for efficient and compliant distribution of drugs, especially for temperature-sensitive and high-value products. Medical Device Manufacturers require specialized logistics for complex devices and regulatory compliance. Hospitals and Healthcare Providers depend on reliable logistics for timely delivery of critical supplies. Clinical Research Organizations need secure and traceable logistics for investigational products, while Wholesalers & Distributors focus on large-scale distribution and inventory management .

Global Healthcare Third Party Logistics Market segmentation by End-User.

Global Healthcare Third Party Logistics Market Competitive Landscape

The Global Healthcare Third Party Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as DHL Supply Chain & Global Forwarding, FedEx Healthcare Solutions, UPS Healthcare, Kuehne + Nagel International AG, DB Schenker, Nippon Express Co., Ltd., Cardinal Health, Inc., AmerisourceBergen Corporation (now Cencora, Inc.), McKesson Corporation, Owens & Minor, Inc., C.H. Robinson Worldwide, Inc., GEODIS, DSV A/S, Expeditors International of Washington, Inc., Rhenus Logistics, Sinotrans Limited, Agility Logistics, Bolloré Logistics, EVERSANA contribute to innovation, geographic expansion, and service delivery in this space.

DHL Supply Chain & Global Forwarding

1969

Germany

FedEx Healthcare Solutions

1971

United States

UPS Healthcare

1907

United States

Kuehne + Nagel International AG

1890

Switzerland

Cardinal Health, Inc.

1971

United States

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Global Healthcare Logistics Revenue (USD, latest FY)

Revenue Growth Rate (Healthcare Segment, %)

Geographic Coverage (Number of Countries/Regions Served)

Number of Healthcare Clients/Contracts

Cold Chain Capacity (Cubic Meters or Pallets)

Global Healthcare Third Party Logistics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Sensitive Products:The global market for temperature-sensitive healthcare products is projected to reach $20 billion in future, driven by the rising prevalence of chronic diseases and the need for effective drug delivery systems. The World Health Organization reported that 41 million people die each year from non-communicable diseases, necessitating reliable logistics for sensitive pharmaceuticals. This demand is further fueled by the expansion of biopharmaceuticals, which require stringent temperature controls during transportation.
  • Rise in E-commerce for Healthcare Products:The e-commerce healthcare market is expected to grow to $200 billion in future, reflecting a significant shift in consumer purchasing behavior. According to the International Trade Centre, online sales of healthcare products surged by 30% in future, driven by convenience and accessibility. This trend is supported by the increasing adoption of digital health solutions, which require efficient logistics to ensure timely delivery of medical supplies and equipment to consumers and healthcare providers.
  • Expansion of Healthcare Infrastructure:Global healthcare expenditure is projected to reach $10 trillion in future, with significant investments in healthcare infrastructure. The World Bank indicates that countries are increasing their healthcare budgets to improve access and quality of care. This expansion necessitates robust logistics solutions to support the distribution of medical supplies, equipment, and pharmaceuticals, thereby driving demand for third-party logistics providers in the healthcare sector.

Market Challenges

  • Regulatory Compliance Complexities:Navigating the regulatory landscape poses a significant challenge for healthcare logistics providers. Compliance with FDA regulations, which require stringent documentation and tracking of pharmaceuticals, can incur costs exceeding $1 million annually for logistics companies. Additionally, the European Union's Medical Device Regulation mandates rigorous standards, complicating cross-border logistics and increasing operational burdens for third-party providers.
  • High Operational Costs:The operational costs for healthcare logistics are estimated to be 20% higher than traditional logistics due to specialized handling and storage requirements. According to industry reports, the average cost of maintaining temperature-controlled environments can reach $2.5 million annually for logistics firms. These elevated costs can hinder profitability and limit the ability of third-party providers to invest in advanced technologies and infrastructure improvements.

Global Healthcare Third Party Logistics Market Future Outlook

The future of healthcare third-party logistics is poised for transformative growth, driven by technological advancements and evolving consumer expectations. As telehealth services expand, logistics providers will increasingly integrate digital solutions to enhance supply chain visibility and efficiency. Furthermore, the emphasis on sustainability will lead to innovative practices in logistics operations, aligning with global environmental goals. The adoption of automation and AI will streamline processes, reduce costs, and improve service delivery, positioning the industry for significant advancements in the coming years.

Market Opportunities

  • Growth in Telehealth Services:The telehealth market is projected to reach $250 billion in future, creating opportunities for logistics providers to support remote patient monitoring and medication delivery. This growth necessitates efficient logistics solutions to ensure timely access to healthcare products, enhancing patient outcomes and satisfaction.
  • Increasing Focus on Patient-Centric Logistics:The shift towards patient-centric logistics is gaining momentum, with healthcare providers prioritizing personalized delivery solutions. This trend is expected to drive demand for tailored logistics services, enabling providers to meet specific patient needs and improve overall healthcare delivery efficiency.

Scope of the Report

SegmentSub-Segments
By Type

Cold Chain Logistics

Non-Cold Chain Logistics

Specialized Logistics Services (e.g., clinical trial logistics, direct-to-patient delivery, hazardous materials handling)

Reverse Logistics & Returns Management

By End-User

Pharmaceutical Companies

Medical Device Manufacturers

Hospitals and Healthcare Providers

Clinical Research Organizations (CROs)

Wholesalers & Distributors

By Service Type

Transportation Services (road, air, sea, rail)

Warehousing & Storage (ambient, cold, hazardous)

Value-Added Services (kitting, labeling, packaging, order fulfillment)

Inventory Management & Supply Chain Visibility

By Product Type

Biopharmaceuticals (vaccines, biologics, biosimilars)

Pharmaceuticals (small molecule drugs)

Medical Devices & Diagnostics

Clinical Trial Materials & Investigational Products

By Delivery Mode

Direct-to-Pharmacy/Hospital Delivery

Direct-to-Patient Delivery

Third-Party Distribution Centers

Scheduled/Routine Delivery

By Geographic Coverage

Global

Regional (e.g., North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Local/Last-Mile Delivery

By Technology Utilization

IoT-enabled Tracking & Monitoring

Blockchain for Supply Chain Transparency

AI and Machine Learning Applications (route optimization, demand forecasting)

Automated Storage & Retrieval Systems (AS/RS)

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Food and Drug Administration, European Medicines Agency)

Pharmaceutical Manufacturers

Medical Device Manufacturers

Healthcare Providers and Hospitals

Logistics and Supply Chain Management Companies

Insurance Companies

Healthcare Technology Companies

Players Mentioned in the Report:

DHL Supply Chain & Global Forwarding

FedEx Healthcare Solutions

UPS Healthcare

Kuehne + Nagel International AG

DB Schenker

Nippon Express Co., Ltd.

Cardinal Health, Inc.

AmerisourceBergen Corporation (now Cencora, Inc.)

McKesson Corporation

Owens & Minor, Inc.

C.H. Robinson Worldwide, Inc.

GEODIS

DSV A/S

Expeditors International of Washington, Inc.

Rhenus Logistics

Sinotrans Limited

Agility Logistics

Bollore Logistics

EVERSANA

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Global Healthcare Third Party Logistics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Global Healthcare Third Party Logistics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Global Healthcare Third Party Logistics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for temperature-sensitive products
3.1.2 Rise in e-commerce for healthcare products
3.1.3 Expansion of healthcare infrastructure
3.1.4 Technological advancements in logistics

3.2 Market Challenges

3.2.1 Regulatory compliance complexities
3.2.2 High operational costs
3.2.3 Limited visibility in supply chains
3.2.4 Risk of product damage during transit

3.3 Market Opportunities

3.3.1 Growth in telehealth services
3.3.2 Increasing focus on patient-centric logistics
3.3.3 Expansion into emerging markets
3.3.4 Adoption of automation and AI in logistics

3.4 Market Trends

3.4.1 Shift towards integrated logistics solutions
3.4.2 Emphasis on sustainability in logistics
3.4.3 Growth of last-mile delivery services
3.4.4 Increasing use of data analytics for decision-making

3.5 Government Regulation

3.5.1 FDA regulations on drug transportation
3.5.2 EU regulations on medical device logistics
3.5.3 Compliance with GDP (Good Distribution Practice)
3.5.4 Environmental regulations impacting logistics operations

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Global Healthcare Third Party Logistics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Global Healthcare Third Party Logistics Market Segmentation

8.1 By Type

8.1.1 Cold Chain Logistics
8.1.2 Non-Cold Chain Logistics
8.1.3 Specialized Logistics Services (e.g., clinical trial logistics, direct-to-patient delivery, hazardous materials handling)
8.1.4 Reverse Logistics & Returns Management

8.2 By End-User

8.2.1 Pharmaceutical Companies
8.2.2 Medical Device Manufacturers
8.2.3 Hospitals and Healthcare Providers
8.2.4 Clinical Research Organizations (CROs)
8.2.5 Wholesalers & Distributors

8.3 By Service Type

8.3.1 Transportation Services (road, air, sea, rail)
8.3.2 Warehousing & Storage (ambient, cold, hazardous)
8.3.3 Value-Added Services (kitting, labeling, packaging, order fulfillment)
8.3.4 Inventory Management & Supply Chain Visibility

8.4 By Product Type

8.4.1 Biopharmaceuticals (vaccines, biologics, biosimilars)
8.4.2 Pharmaceuticals (small molecule drugs)
8.4.3 Medical Devices & Diagnostics
8.4.4 Clinical Trial Materials & Investigational Products

8.5 By Delivery Mode

8.5.1 Direct-to-Pharmacy/Hospital Delivery
8.5.2 Direct-to-Patient Delivery
8.5.3 Third-Party Distribution Centers
8.5.4 Scheduled/Routine Delivery

8.6 By Geographic Coverage

8.6.1 Global
8.6.2 Regional (e.g., North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
8.6.3 Local/Last-Mile Delivery

8.7 By Technology Utilization

8.7.1 IoT-enabled Tracking & Monitoring
8.7.2 Blockchain for Supply Chain Transparency
8.7.3 AI and Machine Learning Applications (route optimization, demand forecasting)
8.7.4 Automated Storage & Retrieval Systems (AS/RS)

9. Global Healthcare Third Party Logistics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Global Healthcare Logistics Revenue (USD, latest FY)
9.2.4 Revenue Growth Rate (Healthcare Segment, %)
9.2.5 Geographic Coverage (Number of Countries/Regions Served)
9.2.6 Number of Healthcare Clients/Contracts
9.2.7 Cold Chain Capacity (Cubic Meters or Pallets)
9.2.8 On-Time Delivery Rate (%)
9.2.9 Regulatory Compliance Certifications (e.g., GDP, ISO 13485)
9.2.10 Technology Adoption Level (IoT, Blockchain, AI)
9.2.11 Customer Retention Rate (%)
9.2.12 Market Penetration Rate (%)
9.2.13 Customer Satisfaction Score (NPS or equivalent)
9.2.14 Sustainability Initiatives (CO? reduction, green fleet %)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 DHL Supply Chain & Global Forwarding
9.5.2 FedEx Healthcare Solutions
9.5.3 UPS Healthcare
9.5.4 Kuehne + Nagel International AG
9.5.5 DB Schenker
9.5.6 Nippon Express Co., Ltd.
9.5.7 Cardinal Health, Inc.
9.5.8 AmerisourceBergen Corporation (now Cencora, Inc.)
9.5.9 McKesson Corporation
9.5.10 Owens & Minor, Inc.
9.5.11 C.H. Robinson Worldwide, Inc.
9.5.12 GEODIS
9.5.13 DSV A/S
9.5.14 Expeditors International of Washington, Inc.
9.5.15 Rhenus Logistics
9.5.16 Sinotrans Limited
9.5.17 Agility Logistics
9.5.18 Bolloré Logistics
9.5.19 EVERSANA

10. Global Healthcare Third Party Logistics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Procurement Processes
10.1.3 Supplier Selection Criteria
10.1.4 Contract Management Practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Logistics Infrastructure
10.2.2 Energy Efficiency Initiatives
10.2.3 Technology Upgrades
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Supply Chain Disruptions
10.3.2 Cost Management Issues
10.3.3 Compliance Challenges
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Technology Adoption Rates
10.4.2 Training and Support Needs
10.4.3 Change Management Strategies
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Use Case Development
10.5.3 Feedback Mechanisms
10.5.4 Others

11. Global Healthcare Third Party Logistics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-Sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Analysis
9.1.3 Packaging Strategies

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership Considerations

12.2 Partnerships Evaluation


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-Term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from healthcare logistics associations and market research firms
  • Review of government publications and healthcare regulations impacting third-party logistics
  • Examination of academic journals and white papers on healthcare supply chain management

Primary Research

  • Interviews with logistics managers at hospitals and healthcare facilities
  • Surveys with third-party logistics providers specializing in healthcare
  • Field interviews with supply chain analysts in pharmaceutical companies

Validation & Triangulation

  • Cross-validation of data through multiple industry sources and expert opinions
  • Triangulation of findings from primary interviews and secondary data sources
  • Sanity checks conducted through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total healthcare expenditure and its allocation to logistics services
  • Segmentation of the market by healthcare sectors such as pharmaceuticals, medical devices, and hospitals
  • Incorporation of trends in telehealth and home healthcare logistics

Bottom-up Modeling

  • Volume estimates based on the number of healthcare facilities and their logistics needs
  • Cost analysis derived from service pricing models of leading third-party logistics providers
  • Calculation of logistics costs per patient and per service type

Forecasting & Scenario Analysis

  • Multi-variable regression analysis incorporating factors like aging population and chronic disease prevalence
  • Scenario modeling based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Logistics Management120Logistics Managers, Supply Chain Directors
Pharmaceutical Distribution90Operations Managers, Compliance Officers
Medical Device Supply Chain60Procurement Officers, Warehouse Managers
Home Healthcare Logistics50Healthcare Administrators, Logistics Coordinators
Telehealth Service Logistics40eHealth Managers, IT Logistics Specialists

Frequently Asked Questions

What is the current value of the Global Healthcare Third Party Logistics Market?

The Global Healthcare Third Party Logistics Market is valued at approximately USD 260 billion, driven by the increasing demand for efficient supply chain solutions and specialized logistics services for sensitive medical products, including pharmaceuticals and medical devices.

What are the key growth drivers for the healthcare third-party logistics market?

Which regions are leading in the healthcare third-party logistics market?

What regulations impact the healthcare third-party logistics market?

Other Regional/Country Reports

Indonesia Healthcare Third Party Logistics Market

Malaysia Healthcare Third Party Logistics Market

KSA Healthcare Third Party Logistics Market

APAC Healthcare Third Party Logistics Market

SEA Healthcare Third Party Logistics Market

Vietnam Healthcare Third Party Logistics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022